A kind of refolding method of recombinant protein

A recombinant protein and protein technology, applied in the field of biochemistry, can solve the problems of control at 10-100 μg/mL or even lower, increase production cost, and not suitable for industrial production, so as to facilitate subsequent purification operations and protein concentration dilution Small and convenient for industrial production

Inactive Publication Date: 2016-02-24
JIANGSU ACAD OF AGRI SCI
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are various problems in the above-mentioned renaturation methods. For example, dialysis renaturation puts the denatured protein into the dialysis bag, and realizes protein renaturation by slowly reducing the concentration of the denaturant. Although the operation is simple, it takes a long time and the processing volume is small. Unable to be applied on a large scale
Dilution renaturation is to dilute the denatured protein solution with water or renaturation buffer to slowly decrease the concentration of denaturant and achieve the purpose of protein renaturation. However, there is no general renaturation buffer at present, and according to current literature reports, by When this method is refolded, the protein concentration needs to be controlled at a low level, which is not suitable for high-concentration proteins. In the current dilution refolding method, the initial protein concentration is generally controlled at 10-100 μg / mL, or even lower
Therefore, the traditional refolding method will dilute the protein in a large amount, which will eventually cause a rapid increase in volume, making it difficult to concentrate the protein in the later stage, and it is not suitable for industrial production.
The renaturation of artificial molecular chaperones is commonly used for Hsp family proteins and GroES / GroEL, etc. Artificial molecular chaperones can significantly increase the protein renaturation rate, but at the same time it will also significantly increase the production cost
Column chromatography renaturation and reverse micelle dissolution renaturation require special materials and equipment, high cost, not suitable for large-scale preparation in the pharmaceutical industry, etc., and the operation process is relatively cumbersome
In conclusion, there is no report on renaturation for initial protein concentration higher than 1 mg / mL.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of refolding method of recombinant protein
  • A kind of refolding method of recombinant protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Embodiment 1 Refolding buffer configuration of recombinant protein

[0012] A) Preparation of the base solution: add 20 mM Tris-HCl and 200 mM NaCl to sterile water, and adjust the pH to 8.0;

[0013] B) adding 4M urea to the base liquid described in step A;

[0014] C) Add β-mercaptoethanol with a volume ratio of 5‰, 1% Tween-20, 10mM β-cyclodextrin and 1M L-cysteine ​​to the step B solution to form a recombinant protein refolding buffer liquid.

Embodiment 2

[0015] The preparation of embodiment 2 initial protein solution

[0016] Preparation of base fluid:

[0017] Add 20mM Tris-HCl and 200mM NaCl to sterile water to adjust the pH to 8.0;

[0018] Add 8M urea to the base solution, stir evenly, and prepare a mixed solution. Dissolve 10 g of the initially purified recombinant porcine inhibin α subunit protein inclusion body in 500 mL of the mixed solution to obtain a recombinant solution with an initial concentration of 20 mg / mL. Porcine inhibin α subunit protein inclusion body solution (hereinafter referred to as initial protein solution).

[0019] The preliminarily purified recombinant porcine inhibin α subunit protein inclusion body involved in this example was obtained by the applicant according to the method disclosed in Chinese patent CN201010618516.4.

Embodiment 3

[0020] Refolding of embodiment 3 recombinant protein

[0021] Preparation of base fluid:

[0022] Add 20mM Tris-HCl and 200mM NaCl to sterile water to adjust the pH to 8.0;

[0023] (1) Slowly add the initial protein solution obtained in Example 2 with a concentration of 20 mg / mL into the recombinant protein refolding buffer (hereinafter referred to as buffer) obtained in Example 1 at 4°C, while stirring slowly, the The volume ratio of the initial protein solution to buffer solution is 1:1; after stirring evenly, centrifuge at 12000rpm for 10min at 4°C to collect the protein supernatant;

[0024] (2) Slowly add the base solution into the buffer to form a diluted refolding buffer, in which the final concentration of urea is 1M, and the volume ratio of the base solution to the buffer is 3:1; the step (1) obtained The protein supernatant was slowly added to the diluted buffer solution at 4°C while stirring slowly. The volume ratio of the protein supernatant to the diluted buffe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a recombinant protein renaturation buffer solution as well as a preparation method and an application thereof. The buffer solution consists of a basis solution, 0.5% of beta-mercaptoethanol, 1% of tween-20, 10mM of beta-cyclodextrin, 1M of L-cysteine and 4M of urea. The preparation method comprises the following steps: firstly, adding 4M of urea into the basis solution, secondly, adding 0.5% of beta-mercaptoethanol, 1% of tween-20, 10mM of beta-cyclodextrin and 1M of L-cysteine according to volume ratio, so as to form the recombinant protein renaturation buffer solution. The buffer solution provided by the invention is applied to recombinant protein renaturation with the primary protein concentration greater than 1mg / mL, is simple to operate, low in cost and convenient in industrial production, the volume after renaturation is slightly increased, the protein concentration is slightly diluted, and the renaturation rate is high.

Description

technical field [0001] The invention relates to the field of biochemistry, in particular to a recombinant protein refolding buffer and its preparation method and application. Background technique [0002] The incomplete modification, misfolding and aggregation of the peptide chain due to the expression of the recombinant protein in bacteria generally exists in the form of inclusion bodies. Break the bacteria to obtain pure inclusion bodies. After being dissolved by denaturant (6M guanidine hydrochloride or 8M urea), the inclusion body must be refolded to make the protein fold correctly, improve solubility and restore biological activity before it can reach the level of clinical application. If the protein cannot be renatured well, it will directly manifest as a decrease in solubility and protein precipitation and precipitation, resulting in a large loss of protein. Due to the limitation of technical level, the renaturation and purification of protein is the bottleneck that ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K1/14
Inventor 李辉施振旦
Owner JIANGSU ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products